Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shannon D. Humphrey"'
Autor:
Jeffrey S. Dover, Shannon D. Humphrey, Z. Paul Lorenc, Ava Shamban, Todd M. Gross, Roman G. Rubio, Domenico Vitarella
Publikováno v:
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 49(1)
Simultaneous treatment of moderate-to-severe upper facial lines is reflective of real-world clinical practice.To evaluate the efficacy and safety of daxibotulinumtoxinA-lanm for injection (DAXI) for simultaneous treatment of glabellar, forehead, and
Autor:
Jean D. Carruthers, Steve Fagien, John H. Joseph, Shannon D. Humphrey, Brian S. Biesman, Conor J. Gallagher, Yan Liu, Roman G. Rubio, Joel L. Cohen, Stephen Ho, Sue Ellen Cox, John Soderberg, Arthur Swift, Daniel Borsuk, Vasilios Papanastasiou, Ava Shamban, Soheil Simzar, Vince Bertucci, Brittany Waller, Charles Boyd, Molly Katz, Lauren Churchill, Stacy Smith, Cheryl Burgess, Karan Dhir, Zoe Draelos, Michael Draelos, Nathan Rosen, Channy Muhn, Ashish C. Bhatia, Shraddha Desai, Te-Shao Hsu, Christopher T. Kelly, Brandice M. Brazell, Jeanine Downie, Bruce Katz, Marianne Woody, Mary Lupo, Skylar Souyoul, Kavita Mariwalla, Joseph Eviatar, Wm. Philip Werschler, Scott Schade, Richard G. Glogau, Derek Jones, Jeanette M. Black, Naissan Wesley, Joely Kaufman-Janette, Joel Schlessinger, Jacqueline Hall, Shea Perillo, Jeffrey Dover, Laurel Morton, Nowell Solish, Gary Monheit, Heidi Essig, Steve Yoelin
Publikováno v:
Plastic and Reconstructive Surgery
Background: DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A formulation in clinical development. A phase 2 dose-ranging study identified an optimal dose and demonstrated efficacy with a median duration of 24 weeks. Methods: